Category: Press Reslease

Global Healthcare IoT Market exhibited a value of USD 66,102.3 million in 2017

Global Healthcare IoT Market exhibited a value of USD 66,102.3 million in 2017

Inpatient management in 2017 held the maximum share in the global healthcare iot market and is expected to witness a significant growth during the forecast period (2018-2025) owing to technological advantage and cost effectiveness – GMI Research

The global healthcare IoT market exhibited a value of USD 66,102.3 million in 2017, and is projected to reach USD 305,980.9 million by 2025, growing at a CAGR of 21.2% during 2018–2025.

Download Sample Brochure : https://tinyurl.com/ya6mhzwo

The key factors boosting the market growth are:
•    Increase in the prevalence of chronic diseases, such as heart failure, obesity, diabetes and hypertension that are boosting the demand for technologically advanced medical devices.
•    New tech generation connected medical devices enabling real-time patient monitoring; thereby, helping the medical professionals to swiftly respond to the patients’ needs.
•    The growing geriatric population, and the high unmet medical needs for home healthcare and long-term healthcare services.

Furthermore, increasing adoption of new generation medical devices at hospitals and clinics, growing incidence of chronic diseases, rising technological advancement and spending on healthcare facilities across the globe have led to the burgeoning market growth of healthcare IoT market.

Medical device product type is expected to dominate the global healthcare IoT market during the forecast period. In 2017, more than half of the market share was held by the medical device. However, systems and software product type is expected to witness the fastest growth rate in the coming years on account of growing adoption among healthcare professionals and patients due to extreme advancement in technology.

The healthcare practitioners are using technology platforms to serve the growing hospital and patient needs. Additionally, numerous routine activities such as patient data recording, storage of data and data analysis have been streamlined using software’s and cloud storage systems, leading to significant reduction in healthcare operational costs and errors. The penetration of technologically advanced connected medical devices, introduction of smart phones, and use of software automation, to enable faster and accurate patient testing, and provide better accuracy, ease of usage & portability is expected to serve Internet of Things in healthcare market as high-impact rendering driver over the forecast period.

“Market leaders and key players consistently investing in research & development activities to keep their leadership in the competitive healthcare IoT market. Further, the healthcare IoT market is witnessing significant growth in Asia-Pacific due to growing number of chronic disease population in the region, specifically, in the countries, such as China and India.”
—-GMI Research

In 2017, North America held the largest share in the market on the back of increased adoption of technology, high volume of hospitals & clinics procedures and need of accurate diagnosis. In addition, there has been a rise in incidence of chronic disease and; hence, increased government and private funding on healthcare infrastructure. Europe is a third fastest growing region for healthcare IoT market and is predicted to grow at a moderate rate during the forecast period.

Key takeaways:
•    In 2017, the hospitals and clinics held most of the market share.
•    Cisco Ltd, Medtronic Plc and Phillips, and IBM are the leading players holding approximately around one third of the market share.
•    The systems and software product type is anticipated to grow at the highest rate during the forecast period from 2018 to 2025.
•    North America region occupied the maximum revenue share in the global healthcare iot market in 2017.

Some of the key players operating in the global healthcare IoT market include Cisco Systems, Inc, Koninklijke Philips N.V, IBM Corporation, Stanley Healthcare, Medtronic plc, Qualcomm Life, Inc, Honeywell Care Solution, Microsoft Corporation, GE Healthcare & Apple Inc and others.

The global healthcare IoT market has been segmented on the basis of product type, application type, end user and key geographies. Based on product type, the global healthcare IoT market comprises of medical devices, systems and software, and services. The application type includes clinical and work flow management, telemedicine, inpatient management and others. The end user segment includes, clinical research organizations, diagnostic laboratories, hospitals & clinics and others.

The research report on healthcare IoT market provides in-depth analysis of the global healthcare IoT market, based on: product type, application type, end user and major geographies for the forecast period from 2018 to 2025. The report highlights the major market drivers propelling the growth as well as challenges faced by the market participants. The research report also provides market size and forecast for healthcare IoT market. The report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

For more details, browse the Table of Contents: https://www.gmiresearch.com/report/global-healthcare-iot-market-2108-2025-share-nih-trends-medical-device-software-application.html


Contact

Sarah Nash
Level 1, The Chase Carmanhall Road,
Sandyford Industrial Estate,
Dublin D18 Y3X2, Ireland
U.S Office +1 860 881 2270
Europe Office +353 1 442 8820
Global Hybrid Operating Room Market exhibited a value of 704.3 million in 2017

Global Hybrid Operating Room Market exhibited a value of 704.3 million in 2017

Growing patient preference for affordable & effective surgical treatments is expected to positively influence the growth of global hybrid operating room market during the forecast period

The global hybrid operating room market exhibited a value of 704.3 million in 2017, and is expected to reach USD 1,572.0 million by 2025, growing at a CAGR of 10.8% during 2018–2025.

Download Sample Brochure : https://tinyurl.com/y7yeo32x

The key factors boosting the market growth are: 
•    Growing minimally invasive surgeries and technological advancement in robot assisted surgeries
•    Rising government & private investments for healthcare facilities infrastructure
•    Increasing awareness and rising patient emphasis on timely and effective disease management

Hybrid operating room is gaining traction in large, urban healthcare facilities due to increasing preference for minimally invasive surgeries, and the massive investments for the development of novel technologies that can help in improving healthcare systems for patients.

Some of the other factors affecting the market growth are technological advancements in the field of robot-assisted surgeries, improved patient outcomes with less invasive procedures, fewer per-procedural complications. Moreover, shorter ICU stays in the hospital directly linked to reduced cost of the procedure which is likely to drive demand for the hybrid operating room market, globally.

Intraoperative diagnostic devices segment holds the largest revenue share in 2017 and is expected to exhibit significant revenue share during the forecast period owing to increasing installation of hybrid ORs across major economies, significant installation costs associated with diagnostic imaging products, ongoing integration and automation of operating room workflows and continuous technological advancements in the field of diagnostic imaging.

Hospital segment holds the largest market share in the 2017 and is predicted to grow at a CAGR 11.4% during the forecast period owing to rising patient emphasis on timely and effective disease management and increasing number of hospitals and surgical centers in developing countries. Also, significant healthcare spending and increasing government & private investments for healthcare facilities infrastructure are expected to lay down the best path for the market to grow

“Strategic collaboration among manufacturers, healthcare providers, accrediting organizations, professional societies, and government agencies may help to design, approve and construct hybrid operating room throughout the world, hence, such collaboration will benefit all stakeholders.”
—-GMI Research

Based on geography, North America held the largest share in the market in 2017 due to significant investments by hospitals to upgrade their operating rooms, increasing number of surgical procedures and ambulatory surgery centers in the region. In addition, presence of advanced medical and healthcare infrastructure is expected to boost the market growth during the forecast period. Asia-Pacific is projected to grow at significant growth rate during 2018-2025 due to rising patient preference for affordable & effective surgical treatments, advancements in operating room technology, rising disposable income, etc.

Key takeaways:
•    The intraoperative diagnostic devices segment is expected to grow at an estimated CAGR of 11.6% during the forecast period,
•    Leading players in the hybrid operating room market, such as General Electric Company, F Koninklijke Philips N.V., and Siemens AG are more focussed strategic collaboration to expand their business.
•    The rapid rise in the volume of minimally invasive surgery has increased demand for hybrid operating room across the globe
•    North America has been a leading region in the installation of hybrid operating suites and construction of hybrid operating rooms

Some of the key players operating in the global hybrid operating room market, include Siemens AG
Toshiba Medicals Systems Corporation, Stryker Corporation, General Electric Company, IMRIS Inc., Koninklijke Philips N.V., Eschmann Holdings Ltd., Getinge AB, TRUMPF Medical Systems, Inc., Skytron LLC., among others.

The global hybrid operating room market has been segmented based on product type, end use and key geographies. Based on the product type which include surgical imaging displays, communication system, intraoperative diagnostic devices, operating tables, surgical booms and others.
Based on end use, the market has been segmented into hospitals, ambulatory surgical centres and others

The research report “global hybrid operating room market” provides in-depth analysis of hybrid operating room across the globe, based on product type, end use and major geographies for the forecast period from 2018 to 2025. The report highlights the major market drivers propelling the growth as well as challenges faced by the market participants. The research report also provides market size and forecast for hybrid operating room market. The report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

For more details, browse the Table of Contents: https://www.gmiresearch.com/report/global-hybrid-operating-room-market-share-trends-forecasts-insights-end-user.html


Contact

Sarah Nash
Level 1, The Chase Carmanhall Road,
Sandyford Industrial Estate,
Dublin D18 Y3X2, Ireland
U.S Office +1 860 881 2270
Europe Office +353 1 442 8820
Global 3D Printed Drugs Market exhibited a value of USD 214.3 million in 2017

Global 3D Printed Drugs Market exhibited a value of USD 214.3 million in 2017

Inkjet Printing technique to proliferate in the global 3D Drugs market and is expected to witness a high growth during the forecast period (2018-2025) owing to technological advantage and rising awareness about the drug – GMI Research

The global 3D printed drugs market exhibited a value of USD 214.3 million in 2017 and is projected to reach USD 295.7 million by 2025, growing at a CAGR of 4.2% during 2018–2025. The key factors boosting the market growth are the technological innovations in 3D printing procedures, the instant solubility of the drug in the mouth, and a rising number of epilepsy patients. Furthermore, increasing adoption of new generation 3D printing technology, growing incidence of epilepsy, rising technological advancement and spending on research and development by the top pharmaceutical companies like GlaxoSmithKline across have led to the burgeoning market growth of 3D printed drug market.

Download Sample Brochure : https://tinyurl.com/y8jranmk

Fused deposition modeling segment is expected to dominate the global 3D printed drugs market during the forecast period. In 2017, more than half of the market share was held by the fused deposition modeling technique. However, the inkjet printing technique type is expected to witness the fastest growth rate in the coming years because of growing adoption among healthcare professionals and patients due to extreme advancement in technology.

Increasing research & development coupled with technological advancement in the pharmaceutical drug are likely to spur the growth of the global 3D printed drugs market in near future.

“To tackle the deadly diseases pharmaceutical companies along with the 3D printing technology players are investing a lot in research and development of the 3D printed drugs. For instance, recently HP partnered with the Centers for Disease Control (CDC) for developing 3D printed drugs for the US’s deadly disease “Superbugs”. Every year around 2.0 million people in the US get directly infected with these superbugs and about 23.0 thousand people die due to the improper medical treatment. It is foreseen that personalized drugs will propel the growth of the 3D printed drugs market by 2025 “
—-GMI Research 

In 2017, North America held the largest share in the market on the back of increased adoption of technology, large volume epilepsy of patients and innovation in 3D drug technology and procedures. In addition, there has been a rise in the incidence of epilepsy disease. Europe has been amongst the growing regions for healthcare 3D printed drugs market and is predicted to grow at a moderate rate during the forecast period.

Buy Report Now @ https://tinyurl.com/y8jranmk

Key takeaways:
•    In 2017, more than half of the market share was held by the fused deposition modeling technique.
•    Apprecia Pharmaceuticals, GlaxoSmithKline and FabRx Ltd, and Hewlett Packard are the leading players holding approximately around one-third of the market share.
•    The inkjet printer product type is anticipated to grow at the highest rate during the forecast period from 2018 to 2025.
•    In 2017, North America held the largest share in the 3D printed drugs market.

Some of the key players operating in the global 3D printed drugs market include 3D Printer Drug Machine, Aprecia Pharmaceuticals, FabRx Ltd, GlaxoSmithKline Plc., Hewlett Packard Caribe, BV, National University of Singapore, The University of Nottingham, UCL School of Pharmacy, University College of London, University of Glasgow and others.

The global 3D printed drugs market has been segmented on the basis of technique type and key geographies. Based on technique type, the global 3D drugs market comprises of fused deposition modeling, inkjet printers, and others also including key geographical areas.

The research report on 3D drugs market provides an in-depth analysis of the global 3D printed drugs market, based on technique type and major geographies for the forecast period from 2018 to 2025. The report highlights the major market drivers propelling the growth as well as challenges faced by the market participants. The research report also provides market size and forecast for 3D printed drug market. The report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

For more details, browse the Table of Contents: https://www.gmiresearch.com/report/global-3d-printed-drugs-market-opportunities-forecast-share-technology-type-insights-company-profile.html


Contact

Sarah Nash
Level 1, The Chase Carmanhall Road,
Sandyford Industrial Estate,
Dublin D18 Y3X2, Ireland
U.S Office +1 860 881 2270
Europe Office +353 1 442 8820
Email: enquiry@gmiresearch.com
Global Neurostimulation Market exhibited a value of USD 5,716.5 million in 2017

Global Neurostimulation Market exhibited a value of USD 5,716.5 million in 2017

Growing demand for safer, more efficient, minimally invasive and more cost-effective procedures for neurological disorders are expected to are expected to drive the adoption rates of neurostimulation devices in the coming years – GMI Research

The global neurostimulation market exhibited a value of USD 5,716.5 million in 2017 and is projected to reach USD 14,476.4 million by 2025, growing at a CAGR of 12.6% during 2018–2025 on account of factors, such as growing prevalence of diseases treatable with neurostimulation, increasing R&D activities for the development of innovative neurostimulation products coupled with rising awareness and high unmet medical needs.

Request Sample Pages : https://tinyurl.com/ya87rn7f

Neurostimulation is gaining traction over conventional pain management procedures due to minimally invasive nature of the surgeries and huge investments for the development of novel technologies that can help in improving healthcare systems for patients.

The key factors bolstering the market growth are increasing prevalence of neurological disorders, such as epilepsy, Parkinson’s disease, dystonia, depression, migraine, and chronic pain. In addition, strong clinical needs, expanding research activities and advancement in neural stimulation technology in combination with a deeper understanding of the nervous system are also likely to drive the market growth during the forecast period.

Implantable spinal cord stimulator segment held the largest revenue share in 2017 and is expected to exhibit significant revenue share during the forecast period owing to increasing number of people suffering from chronic pain and rising awareness about spinal cord stimulator. Introduction of advanced technologies and products, such as adaptiveStim technology, neurowave medical technologies, MRI safety incorporated devices and rechargeable spinal cord stimulators are likely to aid the market growth in the coming years.

Hospital segment captured the largest share in 2017 and is predicted to grow at a CAGR 13.1% during the forecast period owing to rising patient emphasis on timely and effective pain management and increasing number of hospitals and neurology clinics in developing countries. Also, significant healthcare spending and increasing government & private investments for healthcare facilities infrastructure are expected to boost the growth of global neurostimulation market during the forecast period.

“Major companies are focussing on research & development activities in order to develop innovative neurostimulation devices that are technologically advanced and are more efficient. The introduction of next-generation Senza II spinal cord stimulation system, portable neuromodulation stimulator (PoNS™) device and MRI safety incorporated devices in the market are expected to boost the demand during the forecast period.” —-GMI Research

Buy Report @ https://tinyurl.com/ya87rn7f

Based on geography, North America held the largest share in the market in 2017 due to the presence of well-developed healthcare infrastructure, growing awareness among individuals about neurostimulation, and increasing adoption of neurostimulation procedures in the region. In 2017, Europe registered a significant growth rate in global neurostimulation market. Asia-Pacific is the fastest growing region in global neurostimulation market and is projected to exhibit a CAGR of 14.2% during 2018-2025 due to the presence of a large patient pool, rising disposable income, etc.

Key takeaways:
•    The implantable spinal cord stimulator product type segment is expected to grow by 2.4X by 2025 compared to 2017.
•    The companies are focussing on research and development activities through strategic research collaborations. For instance, in August 2018, ElectroCore, Inc. and Massachusetts General Hospital collaborated for research on Non-Invasive Vagus Nerve Stimulation.
•    Boston Scientific Corporation, Medtronic plc, Abbott laboratories, Nevro Corp are the leading players holding the maximum market share.

Some of the key players operating in global neurostimulation market include Boston Scientific Corporation, Medtronic plc, Cyberonics Inc., Nevro Corp, NeuroPace, Inc., Depuy Synthes, NeuroSigma, Inc., Synapse Biomedical Inc., MED-EL. among others.

The global neurostimulation market has been segmented on the basis of product type, indication type, end users and key geographies. Based on the product type, global neurostimulation market has been segmented into implantable and non-implantable. Wherein, implantable segment includes deep brain stimulators, sacral nerve stimulator, spinal cord stimulators, vagus nerve stimulators and others and non-implantable segment includes transcranial magnetic stimulation (TMS) and transcutaneous electrical nerve stimulation (TENS).

Based on indication type, global neurostimulation market has been segmented into chronic pain, movement disorders, epilepsy and others.

Based on end user, the market has been segmented into hospitals, ambulatory surgical centers and specialty clinics.

The research report “global neurostimulation market” provides in-depth analysis of neurostimulation market across the globe, based on product type, indication, end use and major geographies for the forecast period from 2018 to 2025. The report highlights the major market drivers propelling the growth as well as challenges faced by the market participants. The research report also provides market size and forecast for neurostimulation market. The report also analyzes the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

For more details, browse the Table of Contents: https://www.gmiresearch.com/report/global-neurostimulation-market-product-type-indication-end-user-opportunities-forecast-share-trends-industry-analysis.html
Early buyers will get customization upto 20% on report

Contact

Sarah Nash
Level 1, The Chase Carmanhall Road,
Sandyford Industrial Estate,
Dublin D18 Y3X2, Ireland
U.S Office +1 860 881 2270
Europe Office +353 1 442 8820
Email: enquiry@gmiresearch.com
North America to continue to lead the anti-epileptic drugs market – GMI Research

North America to continue to lead the anti-epileptic drugs market – GMI Research

The global Anti-Epileptic Drugs market was valued at USD 3,323.7 million in 2017 and is projected to reach USD 4,458.1 million by 2025, growing at a CAGR of 3.8% during 2018–2025. The major factors driving the anti-epileptic drugs market is the rising awareness about epilepsy, new drug approvals, and drug structure advancements in Anti-Epileptic Drugs industry are likely to drive the growth of the global Anti-Epileptic Drugs market in near future.

Furthermore, advancements in medication management and healthcare services with the increasing number of drug approvals across the globe have led to the burgeoning market growth of Anti-Epileptic Drugs market.

Request Sample Brochure  : https://tinyurl.com/y776x8ar

Valproic Acid drug segment is expected to dominate global Anti-Epileptic Drugs market during the forecast period. In 2017, about one-fourth of the market share was held by Valproic Acid drug in the component segment. However, the highest growth rate is expected to be witnessed by the Lacosamide component segment during the forecast period owing to the increase in usage in the treatment of partial-onset seizures.

“Players are investing a lot in developing and introducing anti-epileptic drugs. For instance, On January 2017, Novartis drug Votubia got approval from EU. This drug will be used for the treatment of refractory partial-onset seizures in patients with TSC. Further, it is foreseen with the growing awareness about the disease and government initiatives the anti-epileptic drugs market will witness significant growth in the emerging markets of Asia-Pacific in the coming 4-5 years .”
—-GMI Research

Based on geography, North America held the largest share in the market in 2017 because of growing awareness about the disease and treatment available, increasing number of rehabs and surgical centers in the region and exponential increase in the epilepsy population. In addition, there has been a rise in the number of approved anti- epileptic drugs. Europe is the second largest region for Anti-Epileptic Drugs market and is expected to grow at a moderate rate during the forecast period.

Buy Report @ https://tinyurl.com/y776x8ar

Key takeaways:
•    In 2017, the Valproic Acid drug type held about one-fourth of the market share.
•    Abbott Laboratories, Cephalon, Inc, Sunovion Pharmaceuticals, and Valeant Pharmaceuticals are the leading players.
•    Lacosamide drug type is anticipated to grow at the highest rate during the forecast period from 2018 to 2025.
•    North America region occupied maximum revenue share in the global Anti-Epileptic Drugs market in 2017.

Some of the key players operating in global Anti-Epileptic Drugs market include Abbott Laboratories, Cephalon, Inc, Sunovion Pharmaceuticals, Valeant Pharmaceuticals International, Sanofi S.A, UCB Pharma Ltd, GlaxoSmithKline plc, Johnson & Johnson, Novartis, AG, Pfizer Inc among others.

The global Anti-Epileptic Drugs market has been segmented on the basis of spectrum type, the market comprises of Narrow and Broad Spectrum. The drug type includes Phenytoin, Phenobarbital, Carbamazepine, Oxcarbazepine, Gabapentin, Pregabalin, Lacosamide, Vigabatrin, Valproic Acid, Lamotrigine, Topiramate, Zonisamide, Levetiracetam, Clonazepam, Rufinamide.

The research report “global Anti-Epileptic Drugs market” provides in-depth analysis of the Anti-Epileptic Drugs market, globally, based on spectrum type, drug type and major geographies for the forecast period from 2018 to 2025. The report highlights the major market drivers propelling the growth as well as challenges faced by the market participants. The research report provides market size and forecast for Anti-Epileptic Drugs market. The report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

For more details, browse the Table of Contents: https://www.gmiresearch.com/report/global-anti-epileptic-drugs-market-opportunities-forecast-by-spectrum-type-share-trends-industry-report.html

Contact

Sarah Nash
Level 1, The Chase Carmanhall Road,
Sandyford Industrial Estate,
Dublin D18 Y3X2, Ireland
U.S Office +1 860 881 2270
Europe Office +353 1 442 8820
Email: enquiry@gmiresearch.com
Global Orthopedic Prosthetics Market was valued at USD 2,759.6 million in 2017

Global Orthopedic Prosthetics Market was valued at USD 2,759.6 million in 2017

Electric powered technology held the largest revenue share in 2017, and is expected to dominate through 2025, growing at a CAGR of 5.3% during 2018-2025 – GMI Research

The global orthopedic prosthetics market was valued at USD 2,759.6 million in 2017, and is projected to reach USD 4,158.2 million by 2025, growing at a CAGR of 5.3% during 2018–2025. The key factors boosting growth of the market are increasing incidence of trauma/accidental injuries, innovations and technological advancement in orthopedic prosthetics technology and introduction of custom-made implant products.

Request Sample Brochure  : https://tinyurl.com/y7vso3qa

Furthermore, increasing adoption of orthopedic prosthetic products at prosthetic clinics, rising technological advancement and spending on healthcare facilities across the globe have led to burgeoning market growth of orthopedic prosthetics market.

Lower limb product type segment is expected to dominate global orthopedic prosthetics market during the forecast period. In 2017, more than half of the market share was held by the lower limb segment. However, the highest growth rate is expected to be witnessed by the upper limb segment during the forecast period owing to growing adoption of upper limb prosthetics among healthcare professionals and patients due to their characteristics of high stability and advanced properties.

Technological advancements in orthopedic prosthetics industry and increasing research & development activities are likely to drive the growth of global orthopedic prosthetics market in near future. Hybrid prosthetics technology in the orthopedic prosthetics market is the upcoming technology to look forward to.

“The companies are focussing on partnership with firms, mergers & acquisitions and investment in research & development activities to keep leadership in the competitive orthopedic prosthetics market. For example: On March, 2016, Zimmer Biomet announced the acquisition of Ortho Transmission and its technology, developed by a US military surgeon, which may improve mobility for amputees.”
—-GMI Research 

Buy Report @ https://tinyurl.com/y7vso3qa

Based on geography, North America held the largest share in the market in 2017 because of large adoption rate of orthopedic prosthetics, high volume of clinical procedures and growth in medical tourism. In addition, there has been a rise in incidence of trauma injuries. Asia-Pacific holds the third largest share in global orthopedic prosthetics market and is expected to grow at a moderate rate during the forecast period.

Key takeaways/key essentials:
•    In 2017, the prosthetic clinics end user type held more than three forth of the market share.
•    Biomet Inc., Johnson & Johnson, and Stryker Corp. are the leading players holding approximately around one third of the market share.
•    The hybrid prosthetics technology type is anticipated to grow at the highest rate during the forecast period from 2018 to 2025.
•    Hybrid prosthetics is the emerging prosthetic technology in the orthopedic prosthetics field, which is intended to cater to the unmet needs of the prosthetic market.
•    North America region occupied maximum revenue share in global orthopedic prosthetics market in 2017.

Some of the key players operating in global orthopedic prosthetics market include, Smith and Nephew plc, Biomet Inc., Johnson & Johnson, Stryker Corp., Otto Bock HealthCare GmbH, Blatchford Ltd, Touch Bionics Inc., Hanger Inc., Fillauer LLC and The Ohio Willow Wood Co.

The global orthopedic prosthetics market has been segmented on the basis of product type, technology type, end user type and key geographies. Based on product type, the market comprises of upper limb, lower limb and others (sockets, fingers, etc).

The technology type comprises of conventional, electric powered and hybrid prosthetics. The end user type comprises of prosthetic clinics, hospitals, rehabilitation centers and others (ASCs, normal clinics, etc).

The research report “global orthopedic prosthetics market” provides in-depth analysis of orthopedic prosthetics market, globally, based on product type, technology type, end user type and major geographies for the forecast period from 2018 to 2025. The report highlights the major market drivers propelling the growth as well as challenges faced by the market participants. The research report also provides market size and forecast for orthopedic prosthetics market. The report also analyzes the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

For more details, browse the Table of Contents: https://www.gmiresearch.com/report/global-orthopedic-prosthetics-market-opportunities-forecast-by-product-type-technology-end-user-share-trends-insights.html

Contact

Sarah Nash
Level 1, The Chase Carmanhall Road,
Sandyford Industrial Estate,
Dublin D18 Y3X2, Ireland
U.S Office +1 860 881 2270
Europe Office +353 1 442 8820
Email: enquiry@gmiresearch.com
Global Orthopedic Prosthetics Market Opportunities & Forecast (2018-2025)-GMI Research

Global Orthopedic Prosthetics Market Opportunities & Forecast (2018-2025)-GMI Research

Global Orthopedic Prosthetics Market, By Product Type (Upper Limb, Lower Limb and Others), By Technology Type (Conventional, Electric Powered and Hybrid Prosthetics), By End User Type (Hospitals, Prosthetic Clinics, Rehabilitation Centers, and Others), and Geography – Opportunities & Forecast, 2018-2025

The global orthopedic prosthetics market was valued at USD 2,759.6 million in 2017, and is projected to reach USD 4,158.2 million by 2025, growing at a CAGR of 5.3% during 2018–2025.

Figure 1: Global Orthopedic Prosthetics Market Revenue, 2018–2025 (USD Million)

Source: GMI Research

The key factors bolstering the market growth are increasing incidence of trauma/accidental injuries, introduction of custom-made implant products, favorable reimbursement for orthopedic prosthetics, rise in prevalence of life-style related diseases and disorders, and growing focus on containment of healthcare costs and distribution.
Based on product type, lower limb is anticipated to lead the market during 2018–2025

Request Sample Brochure  : https://tinyurl.com/y7vso3qa

Lower limb segment is expected to hold maximum share in the market during the forecast period due to innovations and technological advancement in the field of healthcare. However, the highest growth rate is predicted to be exhibited by upper limb segment during the forecast period owing to surging adoption of upper limb orthopedic prosthetics among healthcare professionals and patients due to their characteristics, such as high stability and technological advanced properties. Additionally, wide availability of technically advanced orthopedic prosthetics and rising demand for custom-made orthopedic prosthetics are likely to push the growth of global orthopedic prosthetics market in the next 8 to 10 years.

Based on technology type, electric powered segment is anticipated to lead the market during 2018–2025
Electric powered technology segment is expected to hold maximum share in the market during the forecast period due to innovations, technological advancement and high stability in the field of medical devices. Hybrid prosthetics segment is predicted to exhibit a high growth rate during the forecast period owing to surging adoption of technology among healthcare professionals.

Based on end user type, prosthetic clinics segment dominates the market and is projected to grow at the highest rate during 2018–2025
The end-user segment includes, hospitals, prosthetic clinics, rehabilitation centers and others. Technological advancement in healthcare industry and increasing research & development activities are likely to drive the growth of this segment. Prosthetic devices have been playing a crucial role in the healthcare facilities, especially in hospitals and prosthetic clinics, owing to their various advantages, such as they are user friendly, stable, technological advanced and nearly restores the normal function of the missing body part. The healthcare practitioners are increasingly using technology platforms to serve the growing hospitals and patients’ needs.

Big players are investing a lot in research & development activities. The companies are focusing on product launches for keeping their leadership in global orthopedic prosthetics market. 

Figure 2: Global Orthopedic Prosthetics Market Revenue, by Region, 2017

Source: GMI Research

North America held the largest share in global orthopedic prosthetics market in 2017 owing to increased government and private funding on healthcare infrastructure, growth in medical tourism and technological awareness in healthcare. Asia-Pacific is predicted to be the third most attractive regional market in global orthopedic prosthetics market and is likely to show steady growth rate in the next few years.

Various notable players operating in global orthopedic prosthetics market include, Smith and Nephew plc, Biomet Inc., Johnson & Johnson, Fillauer LLC, Stryker Corp., Otto Bock HealthCare GmbH, Blatchford Ltd, Touch Bionics Inc., Hanger Inc., and The Ohio Willow Wood Co.

The global orthopedic prosthetics market has been segmented on the basis of product type, technology type, end user type and key geographies. Based on product type, the market comprises of upper limb, lower limb and others (sockets, fingers, etc). The technology type includes conventional, electric powered and hybrid prosthetics. The end user type includes hospitals, prosthetic clinics, rehabilitation centers & others (ASCs, normal clinics, etc.).

The research report “global orthopedic prosthetics market” provides in-depth analysis of the orthopedic prosthetics market, globally, based on product type, technology type, end user type and major geographies for the forecast period from 2018 to 2025. The report highlights the major market drivers propelling the growth as well as challenges faced by the market participants. The research report provides market size and forecast for orthopedic prosthetics market. The report also analyzes the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

Key questions answered in this research report:
1-    At what pace is the orthopedic prosthetics market growing worldwide? What will be the growth trend in future?
2-    What are the key drivers and restraints in the current market? What will be the impact of drivers and restraints in the coming years?
3-    What are the regional revenue and forecast breakdowns? Which are the major regional revenue pockets for growth in global orthopedic prosthetics market?
4-    What are the various application areas and how they are poised to grow?

For Sample Pages & Detailed Report Description Click  @  https://www.gmiresearch.com/report/global-orthopedic-prosthetics-market-opportunities-forecast-by-product-type-technology-end-user-share-trends-insights.html

Table of Contents (TOC)

1.    Executive Summary

2.    Introduction      
2.1.    Study Objectives
2.2.    Market Definition
2.2.1.     Market Covered
2.2.2.    Geographical Coverage
2.2.3.    Study Years & Currency
2.3.    Market Stakeholders
2.4.    Key Questions this Study will Answer
2.5.    GMI Research’s Approach & Methodology
3.    Global Orthopedic Prosthetics Market – Overview
3.1.    Introduction         `
3.2.    Market Segmentation
3.3.    Pipeline Analysis
3.4.    Drivers
3.5.    Restraints
3.6.    Trends
4.    Global Orthopedic Prosthetics Market Revenue Forecast till 2025

5.    Global Orthopedic Prosthetics Market by Product Type Revenue Forecast till 2025 
5.1.    Upper Limb
5.2.    Lower Limb
5.3.    Others
6.    Global Orthopedic Prosthetics Market by Technology Type Revenue Forecast till 2025
6.1.    Conventional Technology
6.2.    Electric Powered Technology
6.3.    Hybrid Technology
7.    Global Orthopedic Prosthetics Market by End User Revenue Forecast till 2025  
7.1.    Hospitals
7.2.    Prosthetic Clinics
7.3.    Rehabilitation Centers
7.4.    Others
8.    Global Orthopedic Prosthetics Market by Geography Revenue Forecast till 2025

8.1.    North America Orthopedic Prosthetics Market Revenue Forecast till 2025
8.1.1.    North America Orthopedic Prosthetics Market by Product Type (Option 1: 25% customization)
8.1.1.1.    Upper Limb
8.1.1.2.    Lower Limb
8.1.1.3.    Others
8.1.2.    North America Orthopedic Prosthetics Market by Technology Type
8.1.2.1.    Conventional Technology
8.1.2.2.    Electric Powered Technology
8.1.2.3.    Hybrid Technology
8.1.3.    North America Orthopedic Prosthetics Market by End User
8.1.3.1.    Hospitals
8.1.3.2.    Prosthetic Clinics
8.1.3.3.    Rehabilitation Centers
8.1.3.4.    Others

8.2.    Europe Orthopedic Prosthetics Market Revenue Forecast till 2025
8.2.1.    Europe Orthopedic Prosthetics Market by Product Type (Option 1: 25% customization)
8.2.1.1.    Upper Limb
8.2.1.2.    Lower Limb
8.2.1.3.    Others
8.2.2.    Europe Orthopedic Prosthetics Market by Technology Type
8.2.2.1.    Conventional Technology
8.2.2.2.    Electric Powered Technology
8.2.2.3.    Hybrid Technology
8.2.3.    Europe Orthopedic Prosthetics Market by End User
8.2.3.1.    Hospitals
8.2.3.2.    Prosthetic Clinics
8.2.3.3.    Rehabilitation Centers
8.2.3.4.    Others
8.3.    Asia Pacific Orthopedic Prosthetics Market Revenue Forecast till 2025
8.3.1.    Asia-Pacific Orthopedic Prosthetics Market by Product Type (Option 1: 25% customization)
8.3.1.1.    Upper Limb
8.3.1.2.    Lower Limb
8.3.1.3.    Others
8.3.2.    Asia-Pacific Orthopedic Prosthetics Market by Technology Type
8.3.2.1.    Conventional Technology
8.3.2.2.    Electric Powered Technology
8.3.2.3.    Hybrid Technology
8.3.3.    Asia-Pacific Orthopedic Prosthetics Market by End User
8.3.3.1.    Hospitals
8.3.3.2.    Prosthetic Clinics
8.3.3.3.    Rehabilitation Centers
8.3.3.4.    Others
8.4.    Rest of the World Orthopedic Prosthetics Market Revenue Forecast till 2025
8.4.1.    Rest of the World Orthopedic Prosthetics Market by Product Type (Option 1: 25% customization)
8.4.1.1.    Upper Limb
8.4.1.2.    Lower Limb
8.4.1.3.    Others
8.4.2.    Rest of the World Orthopedic Prosthetics Market by Technology Type
8.4.2.1.    Conventional Technology
8.4.2.2.    Electric Powered Technology
8.4.2.3.    Hybrid Technology
8.4.3.    Rest of the World Orthopedic Prosthetics Market by End User
8.4.3.1.    Hospitals
8.4.3.2.    Prosthetic Clinics
8.4.3.3.    Rehabilitation Centers
8.4.3.4.    Others

9.    Competitive Landscape  
9.1.    Industry Attractiveness
9.2.    Porter 5 Analysis
9.3.    Major players and their key strategies
9.4.    Company Share Analysis
10.    Company Profiles (Option 5: 25% Customization – Profiles of 5 Additional Companies of your Choice)
10.1.    Smith and Nephew Plc
10.1.1.    Company Overview
10.1.2.    Financials
10.1.3.    Recent Developments
10.2.    Zimmer Biomet, Inc.
10.2.1.    Company Overview
10.2.2.    Financials
10.2.3.    Recent Developments
10.3.    Johnson & Johnson Inc
10.3.1.    Company Overview
10.3.2.    Financials
10.3.3.    Recent Developments
10.4.    Fillauer LLC
10.4.1.    Company Overview
10.4.2.    Financials
10.4.3.    Recent Developments
10.5.    Stryker Corp
10.5.1.    Company Overview
10.5.2.    Financials
10.5.3.    Recent Developments
10.6.    Otto bock HealthCare GmbH
10.6.1.    Company Overview
10.6.2.    Financials
10.6.3.    Recent Developments
10.7.    Blatchford Ltd
10.7.1.    Company Overview
10.7.2.    Financials
10.7.3.    Recent Developments
10.8.    Touch Bionics Inc
10.8.1.    Company Overview
10.8.2.    Financials
10.8.3.    Recent Developments
10.9.    Hanger, Inc
10.9.1.    Company Overview
10.9.2.    Financials
10.9.3.    Recent Developments
10.10.    The Ohio Willow Wood Co.
10.10.1.    Company Overview
10.10.2.    Financials
10.10.3.    Recent Developments
11.    About GMI Research

Buy Report @ https://tinyurl.com/y7vso3qa

Related Report :

Global Anti-Epileptic Drugs Market, By Spectrum Type (Narrow Spectrum and Broad Spectrum), By Drug (Phenytoin, Phenobarbital, Carbamazepine, Oxcarbazepine, Gabapentin, Pregabalin, Lacosamide, Vigabatrin, Valproic Acid, Lamotrigine, Topiramate, Zonisamide, Levetiracetam, Clonazepam, Rufinamide) and Geography – Opportunities & Forecast, 2018-2025

About US

GMI Research is a market research and consulting firm which provides research-based solutions to business executives and investment professionals so that they can make right business & investment decisions faster based on real facts. We help business leaders through independent fact-based insight, ensuring their business achieve success by beating the competition.

GMI Research leverages its industry expertise and experience to identify the industry trends, big opportunities and potential growth areas across industries. Our Syndicated reports provide actionable insights and covers industry trends, market drivers & restraints, macroeconomics factors, market estimates & forecasts, competitive landscape etc. which helps our clients to strengthen its market position by deploying specific strategies and actions that will lead to higher growth. 

Our Customized Research (Market Intelligence and Competitive Intelligence) Offerings

Our clients rely on us for the range of our services to give them the intelligence they need to act decisively. GMI Research offers in-depth market and competitive intelligence solutions by leveraging its industry knowledge and experience to provide accurate insights with a complete picture of the market and competition. To know more about our product offering click on the below link:https://www.gmiresearch.com/productservices/marketcompetitiveintelligence.html

Our Company Profile Solution

Company Profiles provide an insight on competitors, customers, and potential suppliers. We at GMI Research understands that the standard or on shelf company profiles provides little help when it comes to business decision making as it doesn’t cover the information required by the clients.

We have developed a range of company profiles solution to meet our client’s specific business requirements irrespective of their role and the industry they operate in. Our company profiles solutions fit into our client’s business requirements because it provides our client’s with a broader choice of profiles: https://www.gmiresearch.com/productservices/companyprofiles.html

Contact – Sarah Nash

Level 1, The Chase Carmanhall Road,
Sandyford Industrial Estate,
Dublin D18 Y3X2, Ireland

U.S Office +1 860 881 2270
Europe Office +353 1 442 8820

Email: sales@gmiresearch.com